The Science of
A brief introduction to Gubra
Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs.
Our focus is the metabolic space (NASH, obesity, diabetes and diabetic complications), where we specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise.
Gubra has been approved as a recognized research organization by the Norwegian Research Council (Forskningsrådet). This means that our Norwegian customers can make use of SkatteFUNN Tax Incentive Scheme for their upcoming R&D expenditures. Our accreditation is valid for 3 years, 2019, 2020, and 2021 – to read more about the potential advantages of this accreditation, please follow this link: https://www.skattefunn.no/prognett-skattefunn/Funding_Opportunities_and_Eligibility/1254001716647?lang=en
Make use of the SkatteFUNN Tax Incentive Scheme with Gubra as your next CRO partner. Don’t hesitate to reach out and let us discuss how we can help progress your next study.
Crédit d’impôt rescherche (CIR)
Gubra have obtained a CIR accreditation from the French Ministry, meaning that we are now recognized as an innovative research provider for companies in France. Our accreditation is valid for 3 years, 2018, 2019 and 2020 and our French customers can therefore claim a tax relief on their outsourced R&D expenditures. Please follow the link below for further information: https://www.service-public.fr/professionnels-entreprises/vosdroits/F23533
Make use of the CIR accreditation with Gubra as your next CRO partner. Don’t hesitate to reach out and let us discuss how we can help progress your next study.
Gubra’s state-of-the-art animal facilities are staffed by trained animal technicians and veterinarians providing professional handling and close monitoring of all research animals.
Gubra is dedicated to ensuring optimal animal welfare and all studies are licensed by the Danish Animal Experimentation Inspectorate and conducted in accordance with the Danish Animal Experimentation Act (BEK nr 12 of 7/01/2016), which is stricter and therefore fully compliant with the European directive (2010/63/EU) and internationally accepted principles for the care and use of laboratory animals.
Gubra applies the 3R principles (replacement, reduction and refinement) to all animal studies and we believe that laboratory animal welfare is an ethical responsibility that encompasses all aspects of animal well-being, including proper housing, clinical and behavioral management, nutrition, disease management and treatment.
Get in touch
If you have further questions regarding our CIR or Skattefunn accreditation and how it might benefit you, or want to discuss how Gubra can help progress your studies, please don’t hesitate to get in touch with us.
Get in touch
“Gubra has succeeded in combining careful design, enlightened scientific methodology and rigorous attention to detail with timely reporting. This is a rare feat for a CRO, and one that sets Gubra apart from other organizations in this space.”
Head of Department of Physiology, Monash University